News
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma June 05, 2019 02:00 AM Eastern Daylight Time ...
Through this agreement, Otsuka Chemical acquires the business of Cefixime from Astellas Pharma to supply the API (Active Pharmaceutical Ingredient) to overseas licensees along with assets such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback